九州通品牌怎么样 申请店铺

我要投票 九州通在减肥药行业中的票数:199 更新时间:2025-01-22
九州通是哪个国家的品牌?「九州通」是 九州通医药集团股份有限公司 旗下著名品牌。该品牌发源于湖北,由创始人刘宝林在2000期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
九州通怎么样

九州通医药集团股份有限公司是一家以药品、医疗器械、生物制品、保健品等产品批发、零售连锁、药品生产与研发及有关增值服务为核心业务的大型企业集团。

截至2012年12月31日,九州通医药集团拥有总资产148.04亿元,员工9,148人,下属公司80余家,直营和加盟的零售连锁药店875家。2012年,九州通医药集团实现营业收入295.08亿元,上缴税收近5亿元。

九州通医药集团拥有完善的品种结构和丰富的客户资源,经营品规达160,000多个,上游供货商5,600家,下游客户70,000多家,取得了国内131种药品的全国或区域总经销或总代理资格。至今为止,九州通医药集团已在全国22个省会城市设立了22家省级子公司(大型医药物流中心)、在29个地级市设立了29家地级公司(地区医药物流配送中心)及400多个终端配送点,形成了覆盖全国大部分县级行政区域的物流配送网络。

打造企业核心竞争力,九州通医药集团秉持“技术让服务更卓越”的理念,致力于现代物流技术和信息技术的开发和应用。目前,九州通医药集团是国内唯一具备独立整合物流规划、物流实施、系统集成能力的医药分销企业,并取得了20多项自主知识产权,在现代物流技术和信息技术方面处于国内领先、国际一流的地位,是国内医药行业唯一获得“中国物流改革开放30年旗帜企业”称号的企业。

九州通医药集团具备向上下游客户提供需求解决方案及增值服务的能力,并逐渐将技术增值服务延伸到了上下游产业链,形成了独具特色的物流管理、供应链管理、医院管理三大产品线,可以满足客户对技术的最高要求。

近年来,九州通医药集团曾获得“国家5A级物流企业”、“湖北省最具影响力民营企业”、“湖北省守合同重信用企业”、“中国社会责任感优秀企业”、“全国非公有制企业双强百佳党组织”等多项荣誉。

未来,九州通医药集团将顺应医药市场变革,继续坚持以医药分销为核心业务,以医院纯销、中药材、医疗器械、零售连锁为战略业务,以物流技术营销、电子商务、国际贸易、原料药等为新兴业务的业务组合战略;扩大和完善医药营销网络布局,不断为医药健康产业提供高性价比服务,努力将九州通打造成为中国医药健康产业最佳服务商。

JIUZHOUTONG Pharmaceutical Group Co., Ltd. is a large-scale enterprise group with the core business of wholesale, retail chain, drug production and R & D and related value-added services of drugs, medical devices, biological products, health products and other products. As of December 31, 2012, JIUZHOUTONG Pharmaceutical Group has a total assets of 14.804 billion yuan, 9148 employees, more than 80 subordinate companies, 875 retail chain drugstores directly operated and joined. In 2012, JIUZHOUTONG Pharmaceutical Group achieved an operating revenue of 29.508 billion yuan and turned in tax revenue of nearly 500 million yuan. JIUZHOUTONG Pharmaceutical Group has a complete variety structure and rich customer resources. It operates more than 160000 products, 5600 upstream suppliers and 70000 downstream customers. It has obtained the qualification of national or regional general distribution or general agent of 131 kinds of drugs in China. So far, JIUZHOUTONG Pharmaceutical Group has set up 22 provincial subsidiaries (large pharmaceutical logistics centers) in 22 provincial capitals, 29 prefecture level companies (regional pharmaceutical logistics distribution centers) and more than 400 terminal distribution points in 29 prefecture level cities, forming a logistics distribution network covering most county-level administrative regions of the country. To build the core competitiveness of the enterprise, JIUZHOUTONG Pharmaceutical Group adheres to the concept of "technology makes service more excellent", and is committed to the development and application of modern logistics technology and information technology. At present, JIUZHOUTONG Pharmaceutical Group is the only pharmaceutical distribution enterprise in China that has the ability to independently integrate logistics planning, logistics implementation and system integration, and has obtained more than 20 independent intellectual property rights. It is in the leading position in modern logistics technology and information technology in China and the first-class position in the world. It is the only one in the domestic pharmaceutical industry that has won the title of "30 years banner enterprise of China's logistics reform and opening up" Enterprises. JIUZHOUTONG Pharmaceutical Group has the ability to provide demand solutions and value-added services to upstream and downstream customers, and gradually extends technology value-added services to the upstream and downstream industrial chains, forming a unique logistics management, supply chain management, hospital management three product lines, which can meet the highest requirements of customers for technology. In recent years, JIUZHOUTONG Pharmaceutical Group has won many honors, such as "national 5A level logistics enterprise", "the most influential private enterprise in Hubei Province", "Hubei Province contract abiding and trustworthy enterprise", "China's outstanding enterprise of social responsibility", "national top 100 Party organizations of non-public enterprises". In the future, JIUZHOUTONG Pharmaceutical Group will continue to adhere to the core business of pharmaceutical distribution, the strategic business of hospital pure sales, Chinese herbal medicine, medical devices, retail chain, the business combination strategy of logistics technology marketing, e-commerce, international trade, API and other emerging businesses, expand and improve the layout of pharmaceutical marketing network, and continue to serve the medical health The industry provides cost-effective services and strives to build Jiuzhoutong into the best service provider in China's pharmaceutical and health industry.

本文链接: https://brand.waitui.com/02808d9a5.html 联系电话:027*****3017 立即查看

千城特选小程序码

7×24h 快讯

“不停科技”完成新一轮A++轮融资

36氪获悉,近日,数字厨房解决方案提供商“不停科技”完成新一轮A++轮融资,融资金额超千万美元。此轮融资由投资机构创世伙伴创投领投,星辰资本担任融资的长期独家财务顾问。这是不停科技继A+轮融资后半年内完成的又一笔融资。目前,不停科技的数字厨房已部署于24个国家和地区,涵盖餐饮、航空、酒店、企业餐饮等多元场景。

2小时前

中美已经或正在沟通关税问题?外交部:愿保持沟通,妥处分歧

外交部发言人毛宁主持例行记者会。外媒记者就关税问题提问,请问中美双方是否已经或正在就关税问题沟通?毛宁表示,“我可以告诉你的是,我们愿意同美方保持沟通,妥善处理分歧,拓展互利合作,推动中美关系稳定、健康、可持续的发展。”(澎湃)

2小时前

佳兆业集团等在深圳成立商务服务合伙企业,出资额24.8亿

36氪获悉,天眼查App显示,近日,深圳市福田佳之园商务服务合伙企业(有限合伙)成立,执行事务合伙人为佳兆业旅游科技(深圳)集团有限公司、深圳锦恒财富管理有限公司,出资额约24.8亿人民币,经营范围包括企业管理咨询、会议及展览服务、信息技术咨询服务等。合伙人信息显示,该企业由佳兆业集团、佳兆业正汉置业(深圳)有限公司、佳兆业城市更新集团(深圳)有限公司等共同出资。

2小时前

浙江2024年以旧换新带动消费超1700亿元

2024年浙江强力推进以旧换新,全省汽车以旧换新累计申请59.4万辆,家电以旧换新700余万台,带动消费超1700亿元。(新华社)

2小时前

春节打车需求将上涨25% 滴滴超4亿元补贴致敬司机保障春运

36氪获悉,滴滴出行数据显示,春运以来,前往机场、火车站的打车订单同比上涨16%,入境用户的滴滴打车订单涨超55%。春节期间,预计打车需求同比上涨25%,滴滴发放超4亿司机补贴、试行节假日司机服务费,致敬假期中辛勤出车的司机师傅们。

2小时前

本页详细列出关于泰尔维亭的品牌信息,含品牌所属公司介绍,泰尔维亭所处行业的品牌地位及优势。
咨询